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http:WHAT THIS PAPER ADDS
The Dutch Surgical Aneurysm Audit (DSAA) is a mandatory registry for risk adjusted hospital outcome mea-
surement and comparison. Thirty day or in hospital mortality for elective abdominal aortic aneurysms (EAAA)
and acute AAA (symptomatic [SAAA] and ruptured [RAAA]) was similar to other national registries. Mortality risk
prediction by V-POSSUM (physiological and operative variables) showed a significant miscalibration with an
overestimation of mortality in EAAA surgery and underprediction in the low risk groups and overprediction in
the high risk groups of SAAA and RAAA surgery. EAAA patients with endovascular aneurysm repair had a
significantly lower observed than predicted mortality, whereas observed mortality was significantly higher than
predicted mortality for RAAA patients receiving open repair. Adjusting hospital mortality for V(p)-POSSUM
(physiological variables only) re-estimated on the DSAA population decreased hospital variation in EAAA pa-
tients, but mortality between hospitals was not discriminative for hospital comparison. Adjusting hospital
mortality by means of V(p)-POSSUM and setting for acute AAA re-estimated on the DSAA was effective and
justifies the modified V(p)-POSSUM as a casemix adjustment model for acute AAA surgery.Objective/Background: The Dutch Surgical Aneurysm Audit (DSAA) is mandatory for all patients with primary
abdominal aortic aneurysms (AAAs) in the Netherlands. The aims are to present the observed outcomes of AAA
surgery against the predicted outcomes by means of V-POSSUM (VascularePhysiological and Operative Severity
Score for the enUmeration of Mortality and Morbidity). Adjusted mortality was calculated by the original and re-
estimated V(physiology)-POSSUM for hospital comparisons.
Methods: All patients operated on from January 2013 to December 2014 were included for analysis. Calibration
and discrimination of V-POSSUM and V(p)-POSSUM was analysed. Mortality was benchmarked by means of the
original V(p)-POSSUM formula and risk-adjusted by the re-estimated V(p)-POSSUM on the DSAA.
Results: In total, 5898 patients were included for analysis: 4579 with elective AAA (EAAA) and 1319 with acute
abdominal aortic aneurysm (AAAA), acute symptomatic (SAAA; n ¼ 371) or ruptured (RAAA; n ¼ 948). The
percentage of endovascular aneurysm repair (EVAR) varied between hospitals but showed no relation to hospital
volume (EAAA: p¼ .12; AAAA: p¼ .07). EAAA, SAAA, and RAAA mortality was, respectively, 1.9%, 7.5%, and 28.7%.
Elective mortality was 0.9% after EVAR and 5.0% after open surgical repair versus 15.6% and 27.4%, respectively,
after AAAA. V-POSSUM overestimated mortality in most EAAA risk groups (p < .01). The discriminative ability of V-
POSSUM in EAAA was moderate (C-statistic: .719) and poor for V(p)-POSSUM (C-statistic: .665). V-POSSUM in AAAA
repair overestimated in high risk groups, and underestimated in low risk groups (p < .01). The discriminative ability
in AAAA of V-POSSUM was moderate (.713) and of V(p)-POSSUM poor (.688). Risk adjustment by the re-estimated
V(p)-POSSUM did not have any effect on hospital variation in EAAA but did in AAAA.
Conclusion: Mortality in the DSAA was in line with the literature but is not discriminative for hospital
comparisons in EAAA. Adjusting for V(p)-POSSUM, revealed no association between hospital volume and
treatment or outcome. Risk adjustment for case mix by V(p)-POSSUM in patients with AAAA has been shown to
be important.responding author. Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
il address: n.lijftogt@gmail.com (N. Lijftogt).
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Auditing hospital outcomes after surgery is a powerful tool
with which to monitor healthcare quality.1 In the
Netherlands several audits for surgical outcomes have been
developed in cooperation with the Dutch Institute for
Clinical Auditing. These audits, meant to improve health-
care, are developed in agreement with several stakeholders,
such as insurance companies and the health inspectorate of
the ministry of healthcare. Complete registration of data
with a minimum of missing values and a motivated
administrative culture are essential for robust and accurate
conclusions for healthcare quality.2 Therefore, a reduced set
of preoperative patient -or disease related variables, easy to
register, is desirable, especially as not every variable regis-
tered and of influence on mortality, needs to be included
for casemix adjustment.3,4
The web based Dutch Surgical Aneurysm Audit (DSAA),
introduced in 2012 and mandatory since 2013, registers all
primary abdominal aortic aneurysm (AAA) operations in the
Netherlands.
Because baseline characteristics of populations may differ
between hospitals, with concomitant differences in outcome,
risk adjustment by patient and disease specific characteristics
for outcomemeasurement is necessary.5 This can be achieved
by using pre-operative variables of influence on the
outcome.6 Numerous models predicting mortality by pre- or
peri-operative variables have been developed for aneurysm
surgery. Only a few of them have been validated multiple
times and are therefore considered as accurate, such as
the Glasgow Aneurysm Score (GAS) or the Vascular
Biochemistry and Haematology OutcomeModel (VBHOM).7,8
The Physiological and Operative Severity Score for the
enUmeration of Mortality and Morbidity (V-POSSUM) is a
well known peri-operative mortality risk prediction
model.9,10 However, the operative variables included in the
model are not suitable for adjustment to compare hospitals
because they are, to a large extent, dependent on surgical
care, such as, for example, blood loss. The “physiology-only”
score of V-POSSUM (V(p)-POSSUM) only contains patient
and disease specific characteristics, which can be suitable as
casemix information for hospital comparisons.
Since the introduction of endovascular aneurysm repair
(EVAR) mortality has decreased in elective AAA surgery
(EAAA); however, the advantage of EVAR over open surgical
repair (OSR) in ruptured abdominal aortic aneurysm (RAAA)
suggested in observational studies has not been confirmed
in randomised trials.11e18 An explanation for differences
between observational research and randomised trials
could be selection bias.16,19 Large registries, of consecutive
patients undergoing surgery for acute aneurysms, might
add insight to this issue. However, the results from national
registries can be difficult to compare owing to differences in
prevalence of RAAA in countries with screening programs,the percentage that refrains from operative repair of RAAA,
and the variation in percentage of EVAR implemented.20e22
The aim of this study was to report the first results of
auditing AAA surgery in the Netherlands. Post-operative
mortality was the primary outcome parameter. As a sec-
ondary outcome parameter, variations in the implementa-
tion of EVAR and the possible association with volume were
investigated. The performance of V-POSSUM, as prediction
model, was assessed. For casemix correction hospital out-
comes were compared and adjusted with the original V(p)-




The DSAA is a mandatory, nationwide, population and web
based database with detailed patient, diagnostic, procedural,
and outcome data of all patients with a primary infra- or
juxtarenal AAA operation in the Netherlands. Under Dutch
law, no ethical approval or informed consent was required.
In 2017 a project will be initiated to validate the existing
data set. Patients prospectively registered in the DSAA,
operated on for an AAA between 1 January 2013 and 31
December 2014 were included for analysis. Excluded were
patients with secondary or revision surgery, surgery of highly
complex aneurysm (suprarenal and thoraco-abdominal), and
mycotic or infected aneurysms.23 Furthermore, patients with
incomplete data concerning date of birth, date of surgery,
survival state, setting, or type of procedure (EVAR/OSR)
were excluded (see “Results”, subsection “Baseline
characteristics”). Patient and treatment characteristics
were described. Procedure for analysis, other than baseline,
was calculated following “intention to treat” analysis and the
percentage of EVAR (EVAR/(EVAR þ OSR)) was tested for the
association with hospital volume. For hospital comparisons
two groups of patients were analysed: EAAA and AAAA.
AAAA was defined as either acute non-ruptured without
extravasation needing surgery within 24h after presentation
(SAAA), or ruptured with extravasation requiring immediate
surgery (RAAA).
Clinical outcomes
The primary outcome measure was 30 day or in hospital
mortality. A sub-analysis was performed, when appropriate,
by year of registration. Other outcome measurements were
peri- and post-operative complications, any re-interventions,
and length of hospital stay. Peri-operative complications
were cardiopulmonary resuscitation, unplanned closure of a
hypogastric artery, and visceral and renal injury. Post-
operative complications concerned bleeding defined as
blood loss needing surgery or blood transfusion; colonic
ischaemia; arterial occlusion; paralysis; prosthesis associated
Table 1. Formula for the calculation of the POSSUM scores.
Model Scoring algorithm þ formula
Risk
prediction










V(p)-POSSUM (ln(R/1  R)) ¼ 6.0386 þ
(0.1539 * physiological score)
R ¼ 1/(1 þ e ˇ(6.0386 þ
(0.1539 * physiological
score)))
522 N. Lijftogt et al.issues (migration, infection, any endovascular leakage); ab-
scess, defined as an abscess of the inguinal wound; abdom-
inal wound or intra-abdominal wounds; visceral
complications (colonic or splenic); wound dehiscence; ileus;
colostomy; major amputation; or profound wound infections
and cardiopulmonary complications; renal insufficiency;
neurological or thromboembolic complications; and in-
fections other than surgical site or pulmonary infections not
directly related to the surgical procedure. Because read-
mission could only be registered as an optional choice of the
DSAA survey it was analysed when registered.
Prediction by V-POSSUM and adjustment by V(p)-POSSUM
The V-POSSUM (operative and physiological score) and V(p)-
POSSUM (only physiological score) were calculated using the
following variables: (i) physiological (age, cardiac comorbid-
ity, pulmonary comorbidity, electrocardiogram status, sys-
tolic blood pressure, pulse rate, haemoglobin, leukocytes,
urea (calculated from creatinine), sodium, potassium, Glas-
gow Coma Scale); (ii) operative (operation severity [severity
of procedure was calculated as “major” for every procedur-
edEVAR and OSRdin accordance with the available litera-
ture], number of procedures, peri-operative blood loss,
peritoneal contamination, malignancy status and setting
[EAAA, SAAA, or RAAA]). Calculations for the V-POSSUM and
V(p)-POSSUM were performed using the formulas shown
in Table 1.9,10,24.25 Predicted mortality was calculated using
the exponent of the V-POSSUM in the following formula:9
Mortality ¼ 1/1 þ exp(V-POSSUM or V(p)-POSSUM)Mortality risk prediction
The observed mortality was compared with the expected (or
predicted) mortality by V-POSSUM using the Hosmer and
Lemeshow test,9,10 which indicates a good calibration when
not significant.9,26 This goodness of fit statistic is computed
as the Pearson chi-square from the contingency table of
observed and expected (predicted) frequencies after having
grouped the observations into deciles based on the pre-
dicted probabilities. The null hypothesis states that there are
no systematic differences between observed and expected
counts in different severity classes. The main idea behind this
test statistic is the more closely the predicted and theobserved frequencies match, the better the fit. Differences
between observed and expected were shown in a bar plot in
terms of percentages. The expected mortality was also
calculated for the different procedures and compared with
the observed mortality, tested according to the Fisher’s
combined probability test. As described earlier, two groups
of patients were analysed: EAAA and AAAA. Combining the
two patient groups having acute surgery was necessary in
order to have an adequate sample size for the acute setting.
When appropriate SAAA and RAAA were analysed separately.Performance comparison
To compare the mortality between centres, an unadjusted
funnel plot was constructed. Next, the adjusted mortality,
based on the V(p)-POSSUM as casemix adjustment, was
computed in a funnel plot to compare the performance of
hospitals in the DSAA with the original British population
(benchmark) on which V(p)-POSSUM was constructed. Note
that V(p)-POSSUM was used rather than V-POSSUM,
because the former is based on pre-operative patient
characteristics (physiology parameters) only. Finally, V(p)-
POSSUM was used as a casemix variable by fitting a logis-
tic regression model on the DSAA data. This allowed a risk
adjusted comparison to be made between the centres in
the DSAA. All results are shown in funnel plots as the
(effective) hospital volume versus the standardised mor-
tality rate (i.e., the ratio of observed to expected events),
together with 95% confidence intervals (CIs).
In the funnel plots two 95% CIs are reported. The orange
narrow one represents a 95% CI that can be used to test the
performance of any particular hospital. A hospital that
actually performs exactly according the national average will
still have 5% probability of falling outside this funnel (i.e.,
false positive). The wider, red 95% CI is corrected for multiple
comparisons by using the Bonferroni correction. This means
that if, for example, all hospitals perform exactly according to
the national average, then there is a 5% probability that at
least one of them will fall outside the red, wider funnel.
Missing data presented as “missing values” in the base-
line tables were allocated to the normal category in V-
POSSUM.27 Normality for continuous variables was tested
by the KolmogoroveSmirnov test and rejected when
p < .05. Medians are presented with an interquartile range;
means are presented with a SD. Analysis was performed in
SPSS version 23.0 (IBM, Armonk, NY, USA).RESULTS
Baseline characteristics
A total of 5979 patients had primary AAA surgery and were
registered in the DSAA during the study period in 65 hos-
pitals. Patients with specific missing data, as is specified
above under “Clinical data” (n ¼ 81; 1.4%), were excluded.
Of the remaining 5898 patients, 4579 patients had EAAA
surgery (77.6%) and 1319 patients had AAAA surgery (RAAA
surgery [n ¼ 948; 16.1%] and SAAA surgery [n ¼ 371;
6.3%]). Almost three quarters of the EAAA patients (74.8%)
Risk-adjusted Abdominal Aortic Aneurysm Outcomes 523were treated primarily by EVAR (74.5% were completed by
EVAR [0.3% converted to OSR]). The majority of AAAA pa-
tients received OSR (60.7%). In the subgroup of patients
with SAAA, 53.6% had EVAR (0.8% converted to OSR) versus
33.8% in patients with RAAA (1.4% converted to OSR). The
converted EVAR were analysed as EVAR according the
“intention to treat” principle. General baseline character-
istics used for V-POSSUM are shown in Tables 2, 3 and 4.Clinical outcomes
Procedure. The variation in percentage of EVAR performed
was wide. In the majority of hospitals >50% of EVAR were
performed in patients with EAAA (range 13e100%) There
was no association between hospital volume and the per-
centage of EVAR performed (p ¼ .12). High AAAA volume
hospitals had a greater preference for EVAR compared with
low volume hospitals, but this was not significant (range 0e
100%; p ¼ .07).
Mortality. The overall 30 day or in hospital mortality after
EAAA surgery was 1.9% versus 7.5% after SAAA and 28.7%
after RAAA surgery. EAAA mortality in 2013 and 2014 was
comparable (1.9% and 2.0%, respectively). Mortality for
AAAA was higher in 2013 than in 2014 in both settings




Male sex, % (95% CI) 86.8 (83.4e87.
Mean  SD age (y) 73  7.7
Median (IQR) diameter (mm) 58 (55e64)
Missing, n (%) 107 (2.3)
Median (IQR) heart rate median (bpm) 72 (63e81)
Missing, n (%) 359 (7.8)
Median (IQR) SBP median (mmHg) 140 (127e152)
Missing, n (%) 278 (6.1)
Comorbidity, % (95% CI)
Cardiac comorbidity
None 46.2 (44.8e47.
Peripheral oedema 8.1 (7.4e9.0)
Elevated CVP 1.4 (1.1e1.7)




Dyspnea during exercise 19.3 (18.2e20.
Invalidating dyspnea 2.7 (2.2e3.2)




Primary only 4.2 (3.6e4.8)
Lymph node metastasis 13.9 (12.9e14.
Distant metastasis 0.6 (0.4e0.8)
Missing 1 (0.7e1.3)
Note. 95% CI: p  (1.96*(SQRT(p*(1  p))/n)), where p ¼ proportion
SAAA ¼ symptomatic abdominal aortic aneurysm; RAAA ¼ rup
IQR ¼ interquartile range; bpm ¼ beats per min; SBP ¼ systolic blooThe overall mortality after AAAA surgery was 22.7% (15.6%
after EVAR vs. 27.4% after OSR). EVAR in EAAA showed a
mortality rate of 0.9% and OSR a mortality rate of 5.0%.
Mortality by procedure and setting is presented in Table 5.
Morbidity. Twenty-three percent (n ¼ 1068) of patients
with EAAA had a peri-operative and/or post-operative
complication. Patients receiving EVAR had fewer complica-
tions than those undergoing OSR (16.1% vs. 44.8%). Almost
39% (n ¼ 144) of the patients with SAAA had one or more
peri- and/or post-operative complications versus 69.2%
(n ¼ 656) of the RAAA patients. Patients undergoing OSR
had a higher percentage of complications than those un-
dergoing EVAR (Tables 5 and 6).
In general, after OSR, there were more complications
than after EVAR. Cardiopulmonary complications accounted
for the most post-operative problems, especially with OSR.
In OSR for EAAA 5.2% of the patients versus 0.2% in EVAR
had renal failure; the majority of these patients (4.6% and
0.1%, respectively) were temporarily dialysed. In the AAAA
group most patients had renal failure after RAAA and OSR
(18.0%). Patients undergoing EVAR had the most unplanned
occlusions of the hypogastric artery during RAAA surgery
(3.2%).
Re-interventions occurred more frequently after OSR than
after EVAR (EAAA 10.7% vs. 2.5%; SAAA 7.0% vs. 9.3%; RAAASAAA RAAA
371 948
8) 81.9 (78.0e85.8) 85.6 (85.8e87.8)
73  8.8 74  8.4
66 (55e80) 78 (65e90)
8 (2.2) 60 (6.3)
79 (69e87) 83 (70e100)
49 (13.2) 131 (13.8)
144 (127e160) 107 (84e135)
42 (11.3) 91 (9.6)
6) 44.5 (39.4e49.6) 40.1 (37.0e43.2)
5.9 (3.2e7.8) 6.4 (4.8e8.0)
2.2 (0.7e3.7) 1.2 (0.5e1.9)
0) 39.4 (34.4e44.4) 28.8 (26.0e31.7)
8.1 (5.3e10.9) 23.5 (20.8e26.2)
6) 73.9 (69.4e78.4) 59.9 (56.8e63.0)
4) 14.8 (11.2e18.4) 15.3 (13.0e17.6)
1.9 (0.5e3.3) 2.8 (1.8e3.9)
1.6 (0.3e2.9) 2.1 (1.2e3.0)
7.8 (5.1e10.5) 19.8 (17.3e22.4)
6) 88.9 (85.7e92.1) 87.1 (85.0e89.2)
2.2 (0.7e3.7) 2.3 (1.4e3.3)
9) 7 (4.4e9.6) 7.2 (5.6e8.9)
1.1 (0.0e2.2) 0.7 (0.2e1.2)
0.8 (0.1 to 1.7) 2.6 (1.6e3.6)
and n ¼ sample size. EAAA ¼ elective abdominal aortic aneurysm;
tured abdominal aortic aneurysm; CI ¼ confidence interval;
d pressure; CVP ¼ central venous pressure.
Table 3. Baseline characteristics: diagnostics.
EAAA SAAA RAAA
Patients (n) 4579 371 948
Diagnostics
Laboratory results
Hemoglobin (mmol/L) 8.8 (8.1e9.3) 8.4 (7.5e9.2) 7.4 (6.4e8.3)
Missing, n (%) 104 (2.3) 7 (1.9) 36 (4.0)
Leukocytes (  109/L) 7.9 (6.6e9.6) 9.0 (7.4e12.0) 12.8 (9.9e16.4)
Missing, n (%) 1727 (37.7) 40 (10.8) 90 (9.5)
Sodium (mmol/L) 140 (138e141) 138 (136e140) 138 (135e140)
Missing, n (%) 387 (8.4) 13 (3.5) 58 (6.1)
Potassium (mmol/L) 4.2 (4.0e4.5) 4.1 (3.8e4.5) 4.0 (3.7e4.4)
Missing, n (%) 288 (6.3) 12 (3.2) 60 (6.3)
Creatinine (mmol/L) 90 (77e108) 85 (70e110) 108 (86e133)
Missing, n (%) 121 (2.6) 14 (3.8) 56 (5.9)
GCS, % (95% CI)
15 90.8 (90.0e91.7) 92.2 (89.0e94.5) 60.9 (57.7e63.9)
12e14 0 1.9 (0.5e3.3) 15.3 (13.1e17.7)
9e11 0 0 3.7 (2.5e4.9)
<9 0 0.5 (0.2 to 1.2) 6.9 (5.3e8.5)
Missing 9.2 (8.4e10.0) 5.4 (3.5e8.2) 13.3 (11.3e15.6)
ECG, % (95% CI)
Normal 60.7 (59.3e62.1) 50.1 (45.1e55.2) 32 (29.1e35.0)
Atrial fibrillation 60e90 bpm 7.1 (6.4e7.9) 6.5 (4.4e9.4) 5.2 (3.9e6.8)
Ischaemia 21.8 (20.6e23.0) 26.4 (22.2e31.1) 17.6 (15.3e20.2)
Missing 10.4 (9.6e11.3) 17 (13.5e21.1) 45.3 (42.1e48.3)
Note. 95% CI: p  (1.96*(SQRT(p*(1  p))/n)), where p ¼ proportion, n ¼ sample size, SQRT ¼ square root. Data are median (IQR) unless
otherwise indicated. EAAA ¼ elective abdominal aortic aneurysm; SAAA ¼ symptomatic abdominal aortic aneurysm; RAAA ¼ ruptured
abdominal aortic aneurysm; GCS ¼ Glasgow Coma Scale; CI ¼ confidence interval; ECG ¼ electrocardiography; bpm ¼ beats per min.
524 N. Lijftogt et al.12.8% vs. 20.7%). A total of 88.5% of patients with EAAA,
treated with EVAR, were discharged within 5 days, and
85.8% of patients undergoing OSR were discharged after >5
days; 19% of the patients undergoing OSR remained in
hospital for >14 days. The majority of patients with RAAA





EVAR completed 74.5 (73.2e75.8)
















Note. 95% CI: p  (1.96*(SQRT(p*(1  p))/n)), where p ¼ proportio
EAAA ¼ elective abdominal aortic aneurysm; SAAA ¼ symptomatic
aneurysm; CI ¼ confidence interval; EVAR ¼ endovascular aneurysm r(12.3% remained in hospital), while 38% of the patients
undergoing OSR remained in hospital for > 14 days.
The variable “readmission” was recorded in 3471 (75.8%)
patients with EAAA and 994 (75.4%) patients with AAAA. Of
those with EAAA, 6.5% were readmitted: 6.2% after EVAR
and 7.1% after OSR. In the AAAA group the majority ofSAAA RAAA
371 948
52.8 (47.7e57.9) 32.4 (29.4e35.4)
0.8 (0.1 to 1.7) 1.4 (0.7e2.2)
46.4 (41.3e51.5) 66.2 (63.2e69.2)
0.5 (0.2 to 1.2) 2.1 (1.2e3.0)
13.7 (10.6e17.6) 7.1 (5.6e8.0)
24.3 (19.9e28.7) 12.1 (10.0e14.2)
12.1 (8.8e15.4) 4 (2.8e5.2)
21 (16.9e25.2) 40.8 (37.7e43.9)
28.8 (24.5e33.7) 36 (33.0e39.1)
93 (90.4e95.6) 76.3 (73.6e79.0)
3 (1.3e4.7) 5.3 (3.9e6.7)
1.1 (0.0e2.2) 0.3 (0.0 to 0.7)
1.3 (0.2e2.5) 14.8 (12.5e17.1)
1.6 (0.3e2.9) 3.5 (2.3e4.7)
n, n ¼ sample size, SQRT ¼ square root. Data are % (95% CI).
abdominal aortic aneurysm; RAAA ¼ ruptured abdominal aortic
epair.
Table 5. Outcome after abdominal aortic aneurysm repair by procedure.
EAAA SAAA RAAA
EVAR OSR EVAR OSR EVAR OSR
Patients (n) 3426 1153 199 172 320 628
Outcome % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Mortality (in hospital
or < 30 d)
0.9 (0.6e1.3) 5.0 (3.9e6.5) 5.0 (2.7e9.0) 10.5 (6.8e16.0) 22.2 (18.0e27.1) 32.0 (28.5e35.8)
Peri-operative
complications
4.1 (3.4e4.8) 6.5 (5.2e8.1) 5.5 (3.1e9.6) 9.9 (6.3e14.3) 13.8 (10.4e18.0) 21.8 (18.8e25.2)
Post-operative
complications
12.5 (11.4e13.6) 42.9 (40.1e45.8) 27.6 (21.9e34.2) 44.2 (37.0e51.7) 49.5 (44.1e55.0) 72.6 (69.0e75.9)
Re-interventions 2.5 (2.0e3.1) 10.7 (9.0e12.6) 7.0 (4.2e13.9) 9.3 (5.8e14.6) 12.8 (9.6e16.9) 20.7 (17.7e24.0)
Hospital stay > 14 d 2.5 19.0 6.0 26.2 16.3 41.2
Hospital stay > 10 d 3.6 33.3 10.1 43.0 25.9 55.1
Hospital stay > 5 d 11.5 85.8 34.2 93.6 54.4 73.1
Hospital readmissiona 6.2 7.1 11.3 9.1 10.3 4.5
Note. 95% CI: p  (1.96*(SQRT(p*(1  p))/n)), where p ¼ proportion, n ¼ sample size, SQRT ¼ square root. EAAA ¼ elective abdominal
aortic aneurysm; SAAA ¼ symptomatic abdominal aortic aneurysm; RAAA ¼ ruptured abdominal aortic aneurysm; EVAR ¼ endovascular
aneurysm repair; OSR ¼ open surgical repair; CI ¼ confidence interval.
a Missing values excluded because not in short survey.
Risk-adjusted Abdominal Aortic Aneurysm Outcomes 525patients were not readmitted to the hospital (92.5%).
Readmissions occurred twice as often after EVAR as after
OSR (10.7% vs. 5.5%).
Risk prediction V-POSSUM
Predicted or expected mortality for EAAA by V-POSSUM
showed significant miscalibration with observed mortality
(HosmereLemeshow p < .01; as reported in Fig. 1A). The
observed mean mortality for EVAR differed significantly
from that predicted (p < .01): 0.9% (95% CI 0.6e1.3) and
3.5% (95% CI 2.9e4.1), respectively. Also, the mean pre-
dicted mortality for EVAR was lower than for OSR. Observed
mortality after OSR was 5% and predicted by V-POSSUM to
be 5.3% (95% CI 4.1e6.6; p ¼ .65), as shown in Table 7. The
overall p value calculated with the Fisher’s combined
probability test showed a significant difference in observed
versus expected mortality (p < .001). The discriminative
ability of V-POSSUM was moderate (C-statistic ¼ .719).
The observed mortality for AAAA surgery by V-POSSUM
showed significant miscalibration (HosmereLemeshow
p< .01) compared with the predicted mortality (Fig. 1B). The
observed mortality for RAAA was 22.2% (EVAR) versus 32.0%
(OSR) and for SAAA 5.0% (EVAR) versus 10.5% (OSR). As
reported in Table 7, predicted mortality was 6.9% (95% CI
3.6e10.2) for EVAR and 9.1% (95% CI 5.0e13.1) for OSR in
patients with SAAA, implying there were no significant dif-
ferences between the observed and predicted percentages.
However, the predicted mortality in RAAA was 21.4% (95% CI
17.4e25.3) for EVAR and 28.6% (95% CI 25.5e31.7) for OSR,
which differed significantly from the observed mortality
(p ¼ .03). The overall p value by Fisher’s combined proba-
bility test showed a non-significant difference in observed
versus expected mortality (p¼ .16). The discriminative ability
of V-POSSUM was moderate (C-statistic ¼ .713).
Risk adjustment V(p)-POSSUM: hospital comparison
The V(p)-POSSUM showed a moderate discriminative ability
of 0.665 in patients with EAAA and 0.688 in patients withAAAA. Unadjusted mortality is shown in Fig. 2A and B for
patients with EAAA and AAAA, respectively.
In both EAAA and AAAA, mortality was low and there was
no evidence of over or underperformance of certain cen-
tres. In Fig. 3A the EAAA DSAA population was compared
with the reference population (i.e., UK) on which the V(p)-
POSSUM was calibrated. A much lower mortality was seen
in the DSAA population, especially in the EVAR group, as
reported in Table 7. In Fig. 3B the AAAA DSAA population is
compared with the reference population (i.e., UK) on which
the V(p)-POSSUM was calibrated. There was a higher mor-
tality in the DSAA population with respect to the reference
population. Finally, in Fig. 4 (A, B) the risk adjusted com-
parison of all centres in the EAAA DSAA and AAAA DSAA is
shown. While for patients with EAAA there is no under- or
overperformance, in AAAA there is no evidence of under-
performance for any centre either, except for one hospital,
which showed a significantly better performance after
multiple testing.DISCUSSION
The 30 day or in hospital mortality of 1.9% for elective AAA
surgery in the Dutch Surgical Aneurysm Audit is comparable
with other European registries. For example, the Swedish
and UK elective populations reported mortality percentages
of 1.5% and 2.4%, respectively.21,23,28 With the Dutch
mandatory minimum volume of 20 AAA operations per year
per centre set by the Dutch Healthcare Inspectorate, mor-
tality was not a discriminative outcome parameter between
hospitals in the DSAA, as almost all unadjusted and adjusted
observations were within the 95% CI. Patients with SAAA
appear to be very different from those with EAAA, indicated
by the mortality rate of 7.5%. The international reported
mortality rate for acute symptomatic, non-ruptured aneu-
rysms ranges between 11% and 18%.29 Mortality after
RAAA surgery in the DSAA was also comparable with mor-
tality after RAAA in the Swedvasc (18% after EVAR, 32%
after OSR in 2013).30 The mortality after EAAA EVAR was
Table 6. Peri- and post-operative complications after abdominal aortic aneurysm repair by procedure.
EAAA SAAA RAAA
EVAR n ¼ 3426 OSR n ¼ 1153 EVAR n ¼ 199 OSR n ¼ 172 EVAR n ¼ 320 OSR n ¼ 628
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
One or more complications
(peri- and post-operative)
16.1 44.8 30.7 48.3 52.5 77.7
CPR 0.1 (0.02e0.02) 0.4 (0.2e1.0) 0.5 (0.09e2.8) 0.6 (0.1e3.2) 5.0 (3.1e8.0) 8.0 (6.1e10.3)
Unplanned closure of
hypogastric artery
1.2 (0.9e1.6) 0.4 (0.2e1.0) 1.5 (0.5e4.3) 0.6 (0.1e3.2) 3.2 (1.7e5.7) 0.9 (0.4e2.0)
Visceral injury peri-operative 0 e 0.5 (0.2e1.1) 0 e 1.2 (0.3e4.1) 0.3 (0.06e1.8) 2.1 (1.2e3.5)
Urethral damage 0 e 0.4 (0.2e1.0) 0 e 0.6 (0.1e3.2) 0 e 0.3 (0.09e1.2)
Other peri-operative 2.7 (2.2e3.3) 4.7 (3.6e6.1) 3.5 (1.7e7.1) 7.0 (4.0e11.8) 5.3 (3.3e8.3) 10.6 (8.4e13.2)
Bleeding 1.0 (0.7e1.4) 2.7 (1.9e3.8) 2.5 (0.1e5.7) 1.2 (0.3e4.2) 2.5 (1.3e4.9) 4.9 (3.5e6.9)
Colonic ischaemia 0.2 (0.1e0.4) 3.7 (2.8e5.0) 1.0 (0.3e3.6) 2.9 (1.2e6.6) 5.3 (3.0e8.3) 9.4 (7.4e11.9)
Arterial occlusion 1.7 (1.3e2.2) 4.0 (3.0e5.3) 1.0 (0.3e3.6) 5.8 (3.2e10.4) 4.4 (2.6e7.2) 5.4 (3.9e7.5)
Paralysis 0 e 0 e 0 e 0 e 0 e 0 e
Any prosthetic complicationsa 1.3 (1.0e1.7) 0.3 (0.1e0.8) 4.0 (2.0e7.7) 0.6 (0.01e3.3) 3.7 (2.1e6.4) 0.3 (0.08e1.1)
Abscess 0 e 0.4 (0.2e1.0) 0.5 (0.09e2.8) 0.6 (0.01e3.3) 0 e 0.8 (0.3e1.9)
Visceral injury post-operative 0 e 0.2 (0.06e0.7) 0 e 0.6 (0.01e3.3) 0.6 (0.2e2.2) 1.5 (0.7e2.5)
Wound dehiscence 0 e 1.6 (1.0e2.5) 0 e 0.6 (0.01e3.3) 0 e 2.1 (1.2e3.6)
Ileus 0.1 (0.04e0.3) 2.7 (1.9e3.8) 0 e 1.7 (0.6e4.9) 0.9 (0.3e2.7) 1.1 (0.5e2.3)
Colostomy 0.1 (0.04e0.3) 3.0 (2.1e4.2) 0 e 1.7 (0.6e4.9) 3.1 (1.7e5.6) 9.2 (7.2e11.7)
Major amputation 0 e 1.0 (0.5e1.8) 0.5 (0.09e2.8) 0.6 (0.01e3.3) 0.3 (0.05e1.7) 1.1 (0.5e2.3)
Profound wound infection 0.8 (0.6e1.2) 0.7 (0.4e1.4) 0 e 0 e 0.6 (0.2e2.2) 0.2 (0.04e1.0)
Other surgical 4.5 (3.9e5.3) 14.6 (12.7e16.8) 11.1 (7.5e16.2) 16.3 (11.5e22.6) 13.4 (10.1e17.6) 23.1 (20.0e26.6)
Cardiac 1.3 (1.0e1.7) 10.1 (8.5e12.0) 6.5 (3.8e10.8) 14.5 (10.0e20.5) 12.5 (9.3e16.6) 19.7 (16.8e23.0)
Pulmonary 1.8 (1.4e2.3) 17.4 (15.3e19.7) 4.5 (2.4e8.4) 19.2 (14.0e25.7) 18.1 (14.3e22.7) 27.2 (23.9e30.8)
Neurological 0.6 (0.4e0.9) 3.6 (2.7e4.9) 1.5 (0.5e4.3) 3.5 (1.6e7.4) 3.4 (1.9e6.0) 7.3 (5.5e9.6)
Thromboembolic 1.4 (1.1e1.9) 4.7 (3.6e6.1) 2.5 (0.1e5.7) 5.2 (2.8e9.6) 4.4 (2.6e7.2) 8.0 (6.1e10.4)
Infectionsb 2.7 (2.2e3.3) 9.5 (7.9e11.3) 5.5 (3.2e9.6) 11.0 (7.2e16.6) 10.0 (7.2e13.8) 18.3 (15.5e21.5)
Renal insufficiency 0.2 e 5.2 (4.1e6.6) 1.0 (2.8e3.6) 8.7 (5.4e13.9) 6.9 (4.6e10.2) 18.0 (15.2e26.9)
Note. 95% CI: p  (1.96*(SQRT(p*(1  p))/n)), where p ¼ proportion, n ¼ sample size, SQRT ¼ square root. EAAA ¼ elective abdominal aortic aneurysm; SAAA ¼ symptomatic abdominal
aortic aneurysm; RAAA ¼ ruptured abdominal aortic aneurysm; EVAR ¼ endovascular aneurysm repair; OSR ¼ open surgical repair; CI ¼ confidence interval; CPR ¼ cardiopulmonary
resuscitation.
a Migration, infection, any leakage.








Figure 1. (A) The percentage observed mortality compared with the percentage expected mortality by V-POSSUM in deciles in elective
AAA. (B) The percentage observed mortality compared with the percentage expected mortality by V-POSSUM in deciles in acute AAA
patients (e.g., symptomatic abdominal aortic aneurysm and ruptured abdominal aortic aneurysm patients).
Risk-adjusted Abdominal Aortic Aneurysm Outcomes 527lower than after OSR in the DSAA and comparable with the
UK data.28 However, mortality after OSR in the DSAA (5%)
compared less favourably with other registries, such as
Swedvasc, which reported 3.2% mortality after OSR in their
yearly report.30 Patients undergoing OSR had a higher
predicted mortality than those undergoing EVAR, which
might be an indication of more comorbidities and also of
more peri-operative blood loss.Table 7. Observed and predicted mortality (V-POSSUM) for abdomina
Procedure Setting Observed Pred
EVAR EAAA 0.88 3.52
OSR EAAA 5.03 5.32
EVAR SAAA 5.03 6.88
OSR SAAA 10.47 9.06
EVAR RAAA 22.19 21.39
OSR RAAA 32.01 28.58
PI ¼ prediction interval; EVAR ¼ endovascular aneurysm repair; EAAA
SAAA ¼ symptomatic abdominal aortic aneurysm; RAAA ¼ ruptured a
Figure 2. (A) The unadjusted standardised mortality ratio (SMR) (y-axis
tients. The x-axis describes the effective sample size, which takes into
case the actual sample size. The expected number of events defined as
intervals (CIs). The green line resembles ‘SMR ¼ 1’ when observed div
hospital mortality for acute abdominal aortic aneurysm patients. The x-a
precision of the estimation of expected events, in this case the actual s
average. The orange and red lines are 95% CIs. The green line resembThe mortality after EVAR in patients with RAAA was
lower compared to OSR, while most RAAA patients were
treated with OSR. The mortality differences between OSR
and EVAR, as in other observational studies, indicate that
selection bias (i.e., different case mix) and a weighed choice
of treatment could be responsible for this observation. The
lower predicted mortality in patients undergoing EVAR
compared with those undergoing OSR might indicate thatl aortic aneurysm patients.







¼ elective abdominal aortic aneurysm; OSR ¼ open surgical repair;
bdominal aortic aneurysm.
) of hospital mortality for elective abdominal aortic aneurysm pa-
account the precision of the estimation of expected events, in this
the national average. The orange and red lines are 95% confidence
ided by expected is the same. (B) The unadjusted SMR (y-axis) of
xis describes the effective sample size, which takes into account the
ample size. The expected number of events defined as the national
les ‘SMR ¼ 1’ when observed divided by expected is the same.
Figure 3. (A) The adjusted standardised mortality ratio (SMR) (y-axis) of hospital mortality for elective abdominal aortic aneurysm patients
by V(p)-POSSUM benchmarked on the UK. The x-axis describes the effective sample size, which takes into account the precision of the
estimation of expected events by V(p)-POSSUM. The expected numbers of patients are calculated by hospital based on the variables
included in V(p)-POSSUM. The green line resembles ‘SMR ¼ 1’ when observed divided by expected is the same. (B) The adjusted SMR (y-
axis) of hospital mortality for acute abdominal aortic aneurysm patients by V(p)-POSSUM benchmarked on the UK. The x-axis describes the
effective sample size, which takes into account the precision of the estimation of expected events by V(p)-POSSUM. The expected numbers
of patients are calculated by hospital based on the variables included in V(p)-POSSUM. The orange and red lines are both 95% confidence
intervals. The green line resembles ‘SMR ¼ 1’ when observed divided by expected is the same.
Figure 4. (A) The adjusted standardised mortality ratio (SMR) (y-axis) of hospital mortality for elective abdominal aortic aneurysm patients
by V(p)-POSSUM re-estimated on the Dutch Surgical Aneurysm Audit (DSAA). The x-axis describes the effective sample size, which takes
into account the precision of the estimation of expected events. The orange and red lines are both 95% confidence intervals (CIs). The
green line resembles ‘SMR ¼ 1’ when observed divided by expected is the same. (B) The adjusted standardised mortality ratio (SMR) (y-
axis) of hospital mortality for acute abdominal aortic aneurysm patients by V(p)-POSSUM re-estimated on the DSAA. The x-axis describes
the effective sample size, which takes into account the precision of the estimation of expected events. The orange and red lines are both
95% CIs. The green line resembles ‘SMR ¼ 1’ when observed divided by expected is the same.
528 N. Lijftogt et al.patients undergoing EVAR had fewer comorbidities, less
peri-operative blood loss, or both. So, when comparing the
results after EVAR and OSR there is at least some selection
bias.16 Conclusions about whether EVAR is a better opera-
tive technique cannot be made from this analysis.
The V-POSSUM is one of the most frequently validated
mortality risk prediction models in the literature. Because all
V-POSSUM variables were implemented in the DSAA, mor-
tality risk adjustment by V(p)-POSSUM, containing only the
pre-operative variables, could be performed easily. Risk
adjustment of outcomes in the DSAA by, for example, V(p)-
POSSUM, in order to compare hospital performances is notperformed by other registries, such as Swedvasc. They do not
risk adjust their yearly outcomes by case mix, which makes
comparisons between registries difficult. Interestingly, in the
DSAA, risk adjustment by V(p)-POSSUM for EAAA did not in-
fluence hospital variation, even after re-estimation on the
Dutch population. This might be caused by the relatively low
event rate of the outcome “mortality”. Perhaps compound
measurements can be the key when comparing hospital
outcomes. Examples are “failure to rescue”, the number of
patients that die as a result of complications, and “textbook
outcome”, the ideal healthcare pathway for every patient.31,32
Risk adjustment for AAAA did change the position on the
Risk-adjusted Abdominal Aortic Aneurysm Outcomes 529y-axis of every hospital, showing the effect of differences in
case mix on mortality and the necessity for risk adjustment.
Missing data
Missing data are a well known and common problem in
registries.2 To maintain data quality, there are several ways of
dealing with missing data. It is possible for instance, to
exclude patients that miss relevant data, to choose imputa-
tion of the mean or use multiple imputation.27,33 Although
missing values are an unwanted outcome, the effect on
hospital outliers is only relevant in low volume hospitals.34
Missing data in the DSAA were scarce and exceeded the
20% for leukocytes in EAAA, which may be a non-routinely
measured variable in patients who undergo AAA surgery.
For peri-operative blood loss, data were missing in >25% in
every setting. Therefore, the percentage of missing values
could indicate poor administrative performance, and a
decrease in the number of missing values might therefore be
used as a quality indicator when comparing hospitals.
Clinical outcomes
It has been suggested that only specialised centres with
appropriate expertise should perform EVAR. However, there
is no significant variation in the outcome of EAAA between
hospitals in the DSAA. Furthermore, there was no rela-
tionship between the percentage of EVAR performed and
hospital volume in the DSAA, as well as no association
between hospital volume (minimum volume of 20 patients
per year) and outcome mortality in both EAAA and AAAA. In
the DSAA almost three quarters of the patients with EAAA
were treated by EVAR. There is no reason to concentrate on
EVAR for EAAA in the Netherlands in the current setting.
However, the volume per centre for primary elective sur-
gery in theNetherlands is 20 tomore than 100 procedures per
year, indicating a volume of five to more than 20 OSRs per
hospital.This number could be challenging formany hospitals,
as several studies have proposed aminimum of 3e12 elective
OSRs per surgeon per year, or at least 7e30 elective OSRs per
hospital per year.35e41 Moreover, as hospital experience in
one procedure does not translate into expertise in the other, it
is necessary to retain experience in both.38 Potential bias in
the outcome of the DSAA can also be caused by the selection
by indication for operation dependent on patient or disease
characteristics (aneurysm diameter, restriction to patients
with comorbidities), and the concomitant choice for a certain
operative technique (OSR or EVAR preference, or even
fenestrated EVAR or chimneys). The choice of operative pro-
cedure influences mortality and depends on patient charac-
teristics as well as on surgeon’s preference. Therefore,
operative variables cannot be used for casemix adjustment,
because a correction for surgical skills is undesirable. Unfor-
tunately, correction for this kind of bias is not possible.
However, the overall mortality rate of 5% for OSR for EAAA is a
matter of concern.The differences in outcome between EVAR
and OSR for AAAA in the DSAA can be biased by “selection by
indication” for surgery. Because results are influenced by
patient or disease characteristics (aneurysm diameter,restriction to patients with comorbidities), and the concom-
itant choice for a certain operative technique (liberal use of
EVARor conservative choice for OSR). Patients receiving EVAR
in the DSAA seem to have less comorbidity. Identifying the
best operative technique for the individual patient remains a
challenge. Vascular units face the challenge of choosing the
surgical technique while at the same time retaining experi-
ence in both open and endovascular techniques.42
Risk prediction V-POSSUM
Mortality risk prediction models like V-POSSUM aim to
predict mortality for an individual patient. Ideally, a model is
discriminative and calibrates well. Because discrimination
and calibration are reversely dependent, this will never be
the case.26 The observed miscalibration of V-POSSUM can
be a sign of overfitting, which can be explained by several
factors: the presence of too many variables compared with
the number of events, the statistical procedure used for
selection of the variables (e.g., forward or backward se-
lection, or high p value for inclusion), the number of cate-
gories used per variable, the handling of missing data, and
the degree to which a population differs from the original
population in severity.26 The significant miscalibration be-
tween observed and expected mortality after EAAA EVAR
can be explained, in part, by the fact that V-POSSUM was
developed before the introduction of EVAR.43 However, in
patients with AAAA mortality was underestimated for those
undergoing OSR, but still higher compared with EVAR.
The discriminative ability was moderate in the DSAA, still
resulting in false predictions compared with the observed
outcomes. This might imply that there are variables lacking
in the model that could lead to better predictions.26
Moreover, according to the instructions of V-POSSUM,
EVAR was scored in the same operative severity category as
OSR (major surgery, 4 points as exponential in the regres-
sion coefficient). It is questionable whether EVAR has to be
marked as major vascular surgery.
Risk adjustment V(p)-POSSUM: hospital comparison
Risk adjusted hospital outcomes are a prerequisite for
meaningful hospital comparisons. Adjusting mortality in the
DSAA with V(p)-POSSUM provides the effect of risk
adjustment by case mix according to the population (UK) in
which V(p)-POSSUM was developed. Therefore, and
because it was built on an overall aneurysm population and
on top of that the continuous predominance of EVAR pro-
cedures, the V(p)-POSSUM was re-estimated for the Dutch
population by logistic regression. The POSSUM physiology-
only models can be a useful tool for comparative
outcome audits.9 However, it might have become necessary
to include more EVAR and outcome specific variables or to
re-estimate the variables included on a mixed (EVAR and
OSR) population. The POSSUM physiology-only models
contain a significant number of variables compared with
other pre-operative mortality-risk prediction models such as
the GAS and VBHOM.7,8 These latter models might be more
suitable and easier to use. Suitability for clinical practice not
530 N. Lijftogt et al.only depends on the number of variables, but also on the
administrative burden in clinical practice. An ideal model
should contain clear and distinct variables, be suitable for
both acute and elective surgery at a definite endpoint, and
have well defined categories. Although, hospital mortality
changed owing to the effect of casemix adjustment, it was
still not possible to recognise underperforming hospitals.
Most hospitals, except one, remained within the CIs.
Limitations
When registering data, coding and documentation errors
(internal validity), or errors in the external validity of the
data, occur. As the registry started in 2013 there were fewer
patients than in 2014. This could have been the result of
under-registration. However, a crude check of mortality
between the two years revealed no differences in mortality
in elective AAA or a registered lower mortality for acute
AAA in 2014. As the data are not yet validated and hospitals
were not audited for data verification, the results presented
in the current overview should be interpreted with care.
The presence of missing data does not necessarily indicate
that a comparison between hospitals is unreliable providing
the volume of AAA repair is large enough and compara-
ble.34 In the Netherlands external validation is difficult
because all AAA operations, including revisions and supra-
renal AAA surgery, are registered nationally in the national
hospital statistics with the same code as primary AAA sur-
gery. Visits to hospitals in order to validate the registered
data will be the next best step in the verification process.
It was not possible to differentiate between referral
centres and non-referral centres in the current DSAA, as
there was no definition for referral centre for highly com-
plex cases. The option of registering the referral of a patient
was recently added to the updated dataset of the DSAA.
Referral centres potentially have more complex aneurysm
morphology with a greater risk of proximal aneurysm neck
related complications and increased mortality.44 Reported
mortality for complex aneurysms is higher than average
AAA, but published results for endovascular repair of diffi-
cult aortic necks look promising.45
Conclusions
Nearly all patients registered in the Dutch Surgical Aneu-
rysm audit could be included for analysis. Operative mor-
tality, adjusted and non-adjusted, after EAAA surgery was
not a discriminative outcome parameter for hospital com-
parisons in the DSAA. The overall post-operative (EVAR and
OSR) and, specifically, EVAR related mortality was low and
there was no significant association between hospital vol-
ume and (risk adjusted) percentage of EVAR performed.
Therefore, the Dutch minimum volume of 20 EAAA pro-
cedures appears to be sufficient for EVAR. However, the
overall mortality after OSR was relatively high, resulting in
concerns with regard to this low volume operation in the
era of preference for EVAR. Also in patients with AAAA, the
observed mortality of OSR for RAAA was significantly higher
than the predicted mortality. Patients undergoing EVARhave a lower mortality, but this can be at least partly
explained by the lower predicted mortality by V-POSSUM,
indicating patient selection. In this study, risk adjusted
mortality for elective AAA surgery has limited capability for
hospital comparison quality assessment.
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Successful TEVAR with a Through and Through Guidewire in an Extremely
Tortuous Aorta
B. Fiorucci a,b,*, N. Tsilimparis a
a Department of Vascular Medicine, German Aortic Centre, Hamburg, Germany
b Unit of Vascular Surgery, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, ItalyAn 83 year old female patient presented acutely with flank pain. Computed tomography angiography (CTA) revealed a
type B aortic dissection with a thoracic false lumen aneurysm of 58 mm in an extremely tortuous aorta. Thoracic endo-
vascular aneurysm repair was performed following establishment of a brachio-femoral through and through guidewire
(Glidewire, Terumo, Japan). Moderate tension was applied to the wire at both ends to straighten the anatomy and permit
graft deployment (A). TX2 and Alpha endografts (Cook Aortic Intervention, Bloomington, IN, USA; 42-38-173 proximally, 38-
34-154 distally) were successfully implanted. Post-operative CTA (B) showed good graft conformability, false lumen
thrombosis and wall apposition without endoleak.rt Centre, University Hospital Hamburg Eppendorf, Martinistr. 52, 20246
ier Ltd. All rights reserved.
